20 search results for: COPD

Understanding IL-33: A Key Factor in <b>COPD</b> Pathogenesis
Pulmonology
Understanding IL-33: A Key Factor in COPD Pathogenesis
interactivity

Explore the role of interleukin (IL)-33 in chronic obstructive pulmonary disease (COPD) pathophysiology and its potential as a therapeutic target.

View more
Role of Type 2 Cytokines in Asthma and <b>COPD</b>
Type 2 Inflammation
Role of Type 2 Cytokines in Asthma and COPD
expert video

Dr Mario Castro explains how type 2 cytokines play a crucial role in airway remodeling and inflammation in asthma and COPD, impacting patient outcomes.

View more
Tailored Medicine in <b>COPD</b>: Understanding Phenotypes, Endotypes, and Genotypes
Pulmonology
Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes
interactivity

This infographic outlines how endotyping, phenotyping, and genotyping are interrelated concepts that are crucial for improving the way patients with COPD are characterized and how understanding these concepts can better optimize patient care

View more
thumbnail
Congress
17
May
2026
Congress
ADVENT at ATS 2026

At ATS 2026, the Sanofi & Regeneron ADVENT Booth #1301 brings together interactive experiences and educational resources to explore Type 2 inflammation as a key feature underlying both asthma and COPD.​

Eosinophils: A Biomarker in <b>COPD</b>
Pulmonology
Eosinophils: A Biomarker in COPD
Infographic

Learn how to identify chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation using blood eosinophil (EOS) levels, understand the associated risks, and recognize factors that may influence EOS counts.

View more
Low Disease Activity and Disease Stability: Setting New Goals for <b>COPD</b> Care
Pulmonology
Low Disease Activity and Disease Stability: Setting New Goals for COPD Care
Infographic

This infographic explores the emerging concepts of disease activity, disease stability, and disease control in COPD.

View more
Impact of Exacerbations in <b>COPD</b>
Type 2 Inflammation
Impact of Exacerbations in COPD
expert video

Dr. Stephanie Christenson discusses the association between COPD exacerbations and the increased risks of morbidity and mortality

View more
Uncovering the Impact of Moderate <b>COPD</b> Exacerbations
Pulmonology
Uncovering the Impact of Moderate COPD Exacerbations
interactivity

The infographic provides information about the clinical characteristics used to classify moderate COPD exacerbations and the impact of these events on lung function, future risk, and mortality.

View more
ERS 2026
Congress
5
September
2026
Congress
ADVENT at ERS 2026

Join Sanofi and Regeneron for four educational symposia on asthma, COPD, and the unified airway.

thumbnail
Congress
19
October
2026
Congress
ADVENT at CHEST 2026

At CHEST 2026, the Sanofi & Regeneron ADVENT Booth #833 brings together interactive experiences and educational resources to explore Type 2 inflammation as a key feature underlying both asthma and COPD.​

World Lung Day 2024
Awareness Day
25
September
2024
Awareness Day
World Lung Day 2024

September 25th marks this year’s observance and celebration of World Lung Day!

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
Pulmonology
Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
interactivity

Learn about the disease burden and heterogeneity of chronic obstructive pulmonary disease (COPD).

View more